IMAX (NYSE:IMAX – Get Free Report) was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued on Saturday.
Several other research analysts have also weighed in on IMAX. Keefe, Bruyette & Woods restated a “market perform” rating and set a $60.00 price objective on shares of IMAX in a research note on Friday, May 22nd. Benchmark reiterated a “buy” rating on shares of IMAX in a report on Monday, June 22nd. Rosenblatt Securities reissued a “buy” rating and set a $47.00 price target on shares of IMAX in a research report on Monday, July 20th. B. Riley Financial upped their price objective on IMAX from $48.00 to $52.00 and gave the company a “buy” rating in a research note on Monday. Finally, Seaport Research Partners reaffirmed a “buy” rating and issued a $50.00 price objective on shares of IMAX in a research report on Wednesday, June 24th. Ten investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $50.36.
Read Our Latest Stock Analysis on IMAX
IMAX Trading Down 1.7%
IMAX (NYSE:IMAX – Get Free Report) last issued its earnings results on Thursday, July 23rd. The company reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.30 by $0.13. IMAX had a net margin of 9.84% and a return on equity of 15.65%. The business had revenue of $102.84 million for the quarter, compared to the consensus estimate of $96.09 million. During the same period in the previous year, the company earned $0.26 earnings per share. The firm’s revenue for the quarter was up 12.2% on a year-over-year basis. As a group, sell-side analysts predict that IMAX will post 1.3 EPS for the current fiscal year.
Insider Activity at IMAX
In related news, CEO Richard L. Gelfond sold 8,943 shares of the company’s stock in a transaction dated Monday, April 27th. The shares were sold at an average price of $37.33, for a total value of $333,842.19. Following the transaction, the chief executive officer owned 765,002 shares in the company, valued at approximately $28,557,524.66. This represents a 1.16% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 20.55% of the company’s stock.
Institutional Investors Weigh In On IMAX
Institutional investors have recently made changes to their positions in the company. Orbis Allan Gray Ltd grew its position in shares of IMAX by 31.7% in the second quarter. Orbis Allan Gray Ltd now owns 5,113,033 shares of the company’s stock valued at $142,960,000 after purchasing an additional 1,230,267 shares during the last quarter. Westfield Capital Management Co. LP lifted its holdings in IMAX by 44.6% during the 4th quarter. Westfield Capital Management Co. LP now owns 2,346,486 shares of the company’s stock worth $86,726,000 after purchasing an additional 723,861 shares during the last quarter. Marsico Capital Management LLC bought a new stake in IMAX in the 4th quarter valued at $18,149,000. Balyasny Asset Management L.P. bought a new stake in IMAX in the 2nd quarter valued at $12,568,000. Finally, Nuveen LLC grew its holdings in IMAX by 253.0% in the 4th quarter. Nuveen LLC now owns 507,377 shares of the company’s stock valued at $18,753,000 after buying an additional 363,658 shares in the last quarter. Institutional investors own 93.51% of the company’s stock.
Trending Headlines about IMAX
Here are the key news stories impacting IMAX this week:
- Positive Sentiment: IMAX reported better-than-expected second-quarter results, with EPS and revenue both topping Wall Street estimates, while management reaffirmed full-year guidance and highlighted margin expansion and network growth. IMAX Corporation Reports Second Quarter 2026 Results
- Positive Sentiment: Strong box-office traction for The Odyssey is boosting confidence that IMAX can sustain higher ticket sales and premium-screen utilization, with reports suggesting the film could be a transformational release for the company. The Odyssey is cleaning up for IMAX. Expect the momentum to continue
- Positive Sentiment: Analysts turned more bullish after earnings, with JPMorgan, Wells Fargo, Barrington, and Wedbush all raising price targets, and Wedbush reiterating Outperform on expectations for a stronger film pipeline, market-share gains, and international expansion. IMAX price target boosted by Wedbush on growth outlook
- Positive Sentiment: Investor attention is also being reinforced by unusual call-option activity and multiple stories about sold-out IMAX 70mm showings, signaling strong near-term demand sentiment around the stock. Imax’s CEO says it’s time to hike prices as tickets to ‘The Odyssey’ resell for $1,000
- Neutral Sentiment: IMAX disclosed a new regulatory risk tied to geopolitical, trade, and other global expansion challenges, which could matter over time but does not appear to be driving near-term trading. IMAX Confronts Rising Geopolitical, Regulatory and Trade Risks Threatening Global Expansion
About IMAX
IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.
Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.
Featured Articles
- Five stocks we like better than IMAX
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.
